Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.
Objective: The aim of this study was to compare the structure of gut microbiota and short-chain fatty acid(SCFAs) in PD with mild cognitive impairment (PD-MCI),…Dysbiosis of Gut Microbiota in a selected population of Italian Parkinson’s Disease patients
Objective: Our main objective was to investigate dysbiosis of gut microbiota in a selected population of Parkinson’s disease (PD) patients from center-south of Italy, examining…The Level of Neuroendocrine Hormones in Parkinson´s Disease and their Potential Role as Biomarkers : A Pilot Study
Objective: To elucidate the role of neuroendocrine hormones in Parkinson’s disease (PD) and evaluate their potential utilization as biomarkers. Background: A growing body of evidence,…Gastrointestinal symptoms as a risk factor for the appearance of motor fluctuations in patients with advanced Parkinson disease
Objective: Gastrointestinal alterations in patients with Parkinson`s Disease (EP) provoke alterations in the absorption of levodopa that facilitates the development of motor fluctuations. Study the…Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study
Objective: To examine whether individuals with a history of Clostridium difficile (C. diff) infection have an elevated risk of developing Parkinson’s disease (PD). Background: The…Antibiotic exposure and Risk for Parkinson’s Disease
Objective: To determine whether antibiotic exposure is associated with Parkinson's disease (PD). Background: Environmental exposures affect the risk of PD and it has been proposed…Outcomes of Percutaneous Endoscopic Gastrostomy (PEG) Feeding in Parkinson’s
Objective: To describe outcomes of PEG feeding in Parkinson's and related disorders. Background: PEG feeding provides a means of getting food, liquid and medication safely…Gastrointestinal symptoms predict cognitive decline in Parkinson’s Disease
Objective: To explore the predictive value of non-motor symptoms on the cognitive decline of patients with Parkinson’s disease (PD) in a three-year follow up. Background:…Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms
Objective: This study was to compare zonisamide and other anti-PD drugs by analyzing their associations with the incidence of PD-relevant symptoms. Background: Patients with Parkinson’s…Evaluation of gut microbiota in patients with Parkinson’s disease using a gas chromatography–mass spectrometry in Russia
Objective: To evaluat of gut microbiota in patients with Parkinson's disease using a gas chromatography–mass spectrometry Background: An increasing number of studies have reported the…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 10
- Next Page »